Dr Reddys Inks commercialisation Deal with Hatchtech
Dr Reddy’s Laboratories has announced the signing of a commercialisation deal with Hatchtech, an Australian pharmaceutical company for developing an […]
Tags: Australia, BSE Sensex, Business Partnership, Business/Finance, Canada, Clinical Research, Dr. Reddy's Laboratories, Drug safety, FDA Phase, food and drug administration, Hatchtech, Health/Medical/Pharmaceuticals, India, lice infestation, medicine, New Drug Application, new zealand, Pediculosis capitis, pharmaceutical, Pharmaceutical industry, Pharmaceutical sciences, Pharmacology, prescription head lice product, PROMIUS PHARMA LLC, russia, United States, US Food and Drug Administration, USD, Venezuela, Xeglyze Lotion
A Cavity-Free Future
Prof Nigel Pitts, Dental Innovation and Translation Centre, Kings College London Dental Institute in conversation with ENN, discusses the issue […]
World News
Sindh makes rapid progress in telemedicinePakistan's Sindh region will set up telemedicine services all its 23 districts very soon. According […]
NEWS REVIEW
[This article was published in the June 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
eHealth News
Hetero bags Government’s anti-flu drug deal
Hyderabad-based Hetero Drugs has bagged the government
Doctors assess patients over long distance wi-fi connection
Residents of remote villages in southern India now have easy access to eye care thanks to a specially designed, low-cost and long-distance wi-fi network.
